Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas F Gajewski

Showing results (181-190 of 236) with videos related to

Pageof 24
Sort By:
Immunity|December 18, 2014
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic TumorsLiufu Deng, Hua Liang, Meng Xu, et al.
Cell Reports|May 12, 2015
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and ImmunityLeticia Corrales, Laura Hix Glickman, Sarah M McWhirter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 26, 2016
NK Cells Restrain Spontaneous Antitumor CD8+ T Cell Priming through PD-1/PD-L1 Interactions with Dendritic CellsXimena L Raffo Iraolagoitia, Raul G Spallanzani, Nicolás I Torres, et al.
The Journal of Clinical Investigation|June 21, 2016
The composition of the microbiota modulates allograft rejectionYuk Man Lei, Luqiu Chen, Ying Wang, et al.
Science Advances|October 7, 2022
Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severityPriscilla S Briquez, Sherin J Rouhani, Jovian Yu, et al.
Medrxiv : the Preprint Server for Health Sciences|November 9, 2021
SARS-CoV-2 infection induces cross-reactive autoantibodies against angiotensin IIPriscilla S Briquez, Sherin J Rouhani, Jovian Yu, et al.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2023
Germline immunomodulatory expression quantitative trait loci (ieQTLs) associated with immune-related toxicity from checkpoint inhibitionRobert Ferguson, Vylyny Chat, Leah Morales, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 29, 2018
Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)Tara C Mitchell, Omid Hamid, David C Smith, et al.
Cancer Chemotherapy and Pharmacology|June 28, 2018
A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumorsAmikar Sehdev, Theodore Karrison, Yuanyuan Zha, et al.
The Lancet. Oncology|July 20, 2014
Combination of vemurafenib and cobimetinib in patients with advanced BRAF(V600)-mutated melanoma: a phase 1b studyAntoni Ribas, Rene Gonzalez, Anna Pavlick, et al.
Pageof 24

Showing results (181-190 of 236) with videos related to

Sort By:
Pageof 24
Immunity|December 18, 2014
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic TumorsLiufu Deng, Hua Liang, Meng Xu, et al.
Cell Reports|May 12, 2015
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and ImmunityLeticia Corrales, Laura Hix Glickman, Sarah M McWhirter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 26, 2016
NK Cells Restrain Spontaneous Antitumor CD8+ T Cell Priming through PD-1/PD-L1 Interactions with Dendritic CellsXimena L Raffo Iraolagoitia, Raul G Spallanzani, Nicolás I Torres, et al.
The Journal of Clinical Investigation|June 21, 2016
The composition of the microbiota modulates allograft rejectionYuk Man Lei, Luqiu Chen, Ying Wang, et al.
Science Advances|October 7, 2022
Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severityPriscilla S Briquez, Sherin J Rouhani, Jovian Yu, et al.
Medrxiv : the Preprint Server for Health Sciences|November 9, 2021
SARS-CoV-2 infection induces cross-reactive autoantibodies against angiotensin IIPriscilla S Briquez, Sherin J Rouhani, Jovian Yu, et al.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2023
Germline immunomodulatory expression quantitative trait loci (ieQTLs) associated with immune-related toxicity from checkpoint inhibitionRobert Ferguson, Vylyny Chat, Leah Morales, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 29, 2018
Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)Tara C Mitchell, Omid Hamid, David C Smith, et al.
Cancer Chemotherapy and Pharmacology|June 28, 2018
A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumorsAmikar Sehdev, Theodore Karrison, Yuanyuan Zha, et al.
The Lancet. Oncology|July 20, 2014
Combination of vemurafenib and cobimetinib in patients with advanced BRAF(V600)-mutated melanoma: a phase 1b studyAntoni Ribas, Rene Gonzalez, Anna Pavlick, et al.
Pageof 24